KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Exelixis (EXEL) over the last 14 years, with Oct 2025 value amounting to $3.4 million.

  • Exelixis' Gains from Investment Securities rose 55.91% to $3.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $214.7 million, marking a year-over-year increase of 16.24%. This contributed to the annual value of $170.5 million for FY2025, which is 8.17% down from last year.
  • According to the latest figures from Q4 2025, Exelixis' Gains from Investment Securities is $3.4 million, which was down 91.66% from $40.5 million recorded in Q3 2025.
  • Over the past 5 years, Exelixis' Gains from Investment Securities peaked at $162.5 million during Q4 2023, and registered a low of -$16.3 million during Q3 2021.
  • Its 3-year average for Gains from Investment Securities is $38.4 million, with a median of $9.8 million in 2023.
  • As far as peak fluctuations go, Exelixis' Gains from Investment Securities tumbled by 466.87% in 2021, and later spiked by 811.73% in 2022.
  • Quarterly analysis of 5 years shows Exelixis' Gains from Investment Securities stood at $75.0 million in 2021, then plummeted by 54.68% to $34.0 million in 2022, then spiked by 378.33% to $162.5 million in 2023, then slumped by 77.32% to $2.2 million in 2024, then spiked by 55.91% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q4 2025, $40.5 million for Q3 2025, and $22.5 million during Q2 2025.